MET monthly performance report
Monthly MET research: returns, drawdown, relative strength, seasonality, and key stats.
MET monthly report
—
Key takeaways
- MetLife (MET) closed August 2026 at $96.26, up 0.14% for the month and +28.54% over the trailing 12 months.
- Year-to-date, MET is +21.94%, outperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +20.66% versus its 200-day moving average ($79.78), a bullish technical signal.
- Over the past three years, MET has underperformed the S&P 500 by −20.77%, with a relative strength index reading of 87.8.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
MetLife ended August 2026 at $96.26, posting a monthly return of +0.14%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −2.91%.
The current quarter stands at +14.68% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +20.66% versus the 200-day moving average ($79.78).
Year-to-date, MET is +21.94% against SPY +12.89%, a gap of +9.06%. The stock is currently −1.57% below its 52-week high, with maximum 3-year drawdown at −23.29%.
| Period | MET | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.14% | −0.20% | +0.33% |
| 1 Week | −1.26% | +3.90% | −5.17% |
| 1 Month | +0.14% | +3.05% | −2.91% |
| 3 Months | +20.17% | +7.11% | +13.06% |
| 6 Months |